The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Significant contract win and Board change

6 Feb 2023 17:30

RNS Number : 0782P
Deepverge PLC
06 February 2023
 

6 February 2023

 

DeepVerge PLC

 

("DeepVerge" or "the Company" or "the Group")

 

Significant contract win and Board change

 

DeepVerge (AIM: DVRG), the environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins, announces a significant contract win, change to the board and to the role undertaken by an existing director.

Significant contract win

Glanaco, a subsidiary of DeepVerge acquired in March 2022, has secured a €10m (circa £9.3m) order from an existing customer in Central Asia for the design, assembly and supply of multi-function mobile equipment for use by municipalities for applications including cleaning, decontaminating, de-icing, and salting streets and public areas, with relevant data generated by the bespoke software designed by the Company's subsidiary Rinocloud.

 

The order comprises a design licensed to the customer, the initial c£3.2m revenues for which were included in the £17.2m (unaudited) total for 2022 announced on 9 January 2023, and production of 100 units which are contracted to be delivered in 2023, starting in March 2023, with revenues of c£6.1m. The order for 100 units will be managed by Glanaco's plant in Cork, Ireland where all assembly and testing will be undertaken.

 

Board and Management changes

Fionan Murray has stepped down from the board with immediate effect to concentrate during his notice period on maximising the value of Skin Trust Club and Labskin Division, in line with the announcement on 20 July 2022 that the Company is exploring a range of options to meet the unprecedented demand for Labskin services and the accelerating growth of Skin Trust Club.

Dr Nigel Burton, interim CEO DeepVerge plc, commented:

"I'm pleased to be able to announce this contract, which is a significant contribution to the 2023 order book and revenues.

 

I'd like to thank Fin for his significant contribution to the development of the Company since the acquisition of Rinocloud in 2019. We wish him well in his future endeavours."

 

DeepVerge plc

Nigel Burton, Interim CEO

+44 (0) 7785 234447

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

Market Abuse Regulation (MAR) Disclosure

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins; Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLDFFIRIIV
Date   Source Headline
1st Feb 20218:30 amRNSAppointment of former IBM Legal Counsel as CoSec
1st Feb 20217:00 amRNSAppointment of former IBM Legal Counsel as CoSec
25th Jan 20212:22 pmRNSExercise of Warrants and Total Voting Rights
18th Jan 20214:51 pmRNSExercise of Options and Total Voting Rights
15th Jan 20217:00 amRNSCompletion of Compulsory Acquisition; TVR
11th Jan 20217:00 amRNSDVRG confirms maiden Q4 profit;guides £10m in 2021
11th Dec 20207:00 amRNSNew Labskin service - update
3rd Dec 20204:26 pmRNSDirector/PDMR Shareholding
1st Dec 20207:00 amRNSTrading Update & Investor Presentation
27th Nov 20207:00 amRNSInterim analysis from Aberdeen Uni - Labskin study
25th Nov 20207:00 amRNSInvestor presentation and corporate update
23rd Nov 20209:26 amRNSHolding(s) in Company
19th Nov 20205:25 pmRNSIssue of Share Options/PDMR Dealings
18th Nov 202012:17 pmRNSTR-1: Notification of major holdings
18th Nov 202011:06 amRNSSecond Price Monitoring Extn
18th Nov 202011:00 amRNSPrice Monitoring Extension
17th Nov 20203:43 pmRNSDirector/PDMR Shareholding
17th Nov 20203:38 pmRNSAllotment of Shares Following Close of Offer
16th Nov 20207:00 amRNSUpdate on detection products
13th Nov 20205:22 pmRNSHolding(s) in Company
10th Nov 20202:57 pmRNSExercise of Warrants and Total Voting Rights
10th Nov 20201:14 pmRNSExchange and Grant of Options and Warrants
10th Nov 20207:00 amRNSAppointment of Non-Executive Director
9th Nov 20205:30 pmRNSDeepverge
9th Nov 20205:02 pmRNSAllotment of Shares and Level of Acceptances
9th Nov 20202:05 pmRNSSecond Price Monitoring Extn
9th Nov 20202:00 pmRNSPrice Monitoring Extension
9th Nov 20208:46 amRNSHolding(s) in Company
9th Nov 20208:06 amRNSOffer Unconditional in all respects
3rd Nov 20203:00 pmRNSOFFER UNCONDITIONAL AS TO ACCEPTANCES; EXTENDED
26th Oct 20206:31 pmRNSForm 8.3 - Deepverge PLC
23rd Oct 20204:41 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
23rd Oct 20204:08 pmRNSComment on detection of COVID-19 in UK Sewage
22nd Oct 20204:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:35 pmRNSPrice Monitoring Extension
22nd Oct 20209:05 amRNSSecond Price Monitoring Extn
22nd Oct 20209:00 amRNSPrice Monitoring Extension
13th Oct 20203:55 pmRNSPublication of Offer Document; Rule 15 letters
13th Oct 20203:45 pmRNSReplacement - Form 8 (OPD) - Modern Water plc
9th Oct 20207:00 amRNSUpdate on Offer for Modern Water plc by DeepVerge
7th Oct 20204:40 pmRNSSecond Price Monitoring Extn
7th Oct 20204:35 pmRNSPrice Monitoring Extension
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
7th Oct 202011:05 amRNSSecond Price Monitoring Extn
7th Oct 202011:00 amRNSPrice Monitoring Extension
7th Oct 20209:05 amRNSSecond Price Monitoring Extn
7th Oct 20209:00 amRNSPrice Monitoring Extension
6th Oct 20205:21 pmRNSForm 8.3 -Deepverge PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.